Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
Sylvia Wheeler Lisa Kelly Croswell Progeroid Laminopathies David Cory Sarah Mathieson Company Annual
Source: prnewswire.com